Combination Drug Therapy: A Strategy for Aggressive Lipid Modification

This continuing feature will update readers on recent developments in cardiovascular pharmacotherapy. Cardiovascular disease remains the number one killer in the US, and more clinical outcome trials have been conducted in cardiology than in any other field of medicine. Given this rapidly expanding knowledge base, pharmacists can have a significant impact on the prevention and treatment of cardiovascular disease—if they keep current with developments in drug therapy.

Download Full-text

The A-HeFT Trial: More Questions than Answers

Hospital Pharmacy ◽

10.1177/001857870504000604 ◽

2005 ◽

Vol 40 (6) ◽

pp. 483-489

Author(s):

Patricia A. Howard

Keyword(s):

Cardiovascular Disease ◽

Drug Therapy ◽

Clinical Outcome ◽

Knowledge Base ◽

Cardiovascular Pharmacotherapy ◽

The Us ◽

Prevention And Treatment ◽

Recent Developments

This continuing feature will update readers on recent developments in cardiovascular pharmacotherapy. Cardiovascular disease remains the number one killer in the US, and more clinical outcome trials have been conducted in cardiology than in any other field of medicine. Given this rapidly expanding knowledge base, pharmacists can have a significant impact on prevention and treatment — if they keep current with developments in drug therapy.

Download Full-text

Hyperkalemia with Combined Aldosterone and Angiotensin Blockade in Patients with Heart Failure

Hospital Pharmacy ◽

10.1310/hpj4105-414 ◽

2006 ◽

Vol 41 (5) ◽

pp. 414-418

Author(s):

Patricia A. Howard

Keyword(s):

Heart Failure ◽

Cardiovascular Disease ◽

Drug Therapy ◽

Clinical Outcome ◽

Cardiovascular Pharmacotherapy ◽

Patients With Heart Failure ◽

The Us ◽

Prevention And Treatment ◽

Recent Developments ◽

Angiotensin Blockade

This continuing feature will update readers on recent developments in cardiovascular pharmacotherapy. Cardiovascular disease remains the number one killer in the US, and more clinical outcome trials have been conducted in cardiology than in any other field of medicine. Given this rapidly expanding knowledge base, pharmacists can have a significant impact on prevention and treatment — if they keep current with developments in drug therapy.

Download Full-text

Amiodarone Prophylaxis: Impact on Atrial Fibrillation and Outcomes after Cardiac Surgery

Hospital Pharmacy ◽

10.1310/hpj4208-680 ◽

2007 ◽

Vol 42 (8) ◽

pp. 680-685

Author(s):

Patricia A. Howard ◽

Brian J. Barnes

Keyword(s):

United States ◽

Atrial Fibrillation ◽

Cardiovascular Disease ◽

Cardiac Surgery ◽

Drug Therapy ◽

Clinical Outcome ◽

The United States ◽

Cardiovascular Pharmacotherapy ◽

Prevention And Treatment ◽

Recent Developments

This continuing feature will update readers on recent developments in cardiovascular pharmacotherapy. Cardiovascular disease remains the number one killer in the United States, and more clinical outcome trials have been conducted in cardiology than in any other field of medicine. Given this rapidly expanding knowledge base, pharmacists can have a significant impact on prevention and treatment—if they keep current with developments in drug therapy.

Download Full-text

The Evolving Role of Angiotensin Receptor Blockers in Heart Failure

Hospital Pharmacy ◽

10.1177/001857870203700505 ◽

2002 ◽

Vol 37 (5) ◽

pp. 474-482

Author(s):

Patricia A. Howard

Keyword(s):

Heart Failure ◽

Cardiovascular Disease ◽

Angiotensin Receptor Blockers ◽

Angiotensin Receptor ◽

Cardiovascular Pharmacotherapy ◽

The Us ◽

Prevention And Treatment ◽

Recent Developments ◽

Receptor Blockers

This continuing feature will update readers on recent developments in cardiovascular pharmacotherapy. Cardiovascular disease remains the number one killer in the US, and more clinical outcome trials have been conducted in cardiology than in any other field of medicine. Given this rapidly expanding knowledge base, pharmacists can have a significant impact on the prevention and treatment of cardiovascular disease—if they keep current with developments in drug therapy.

Download Full-text

The Impact of NSAIDs on the Risk of Coronary Heart Disease

Hospital Pharmacy ◽

10.1177/001857870203700902 ◽

2002 ◽

Vol 37 (9) ◽

pp. 919-926

Author(s):

Patricia A. Howard

Keyword(s):

Cardiovascular Disease ◽

Kansas City ◽

Medical Center ◽

Pharmacy Practice ◽

University Of Kansas ◽

Cardiovascular Pharmacotherapy ◽

The Us ◽

Recent Developments ◽

The Impact ◽

E Mail

This continuing feature will update readers on recent developments in cardiovascular pharmacotherapy. Cardiovascular disease remains the number one killer in the US, and more clinical outcome trials have been conducted in cardiology than in any other field of medicine. Given this rapidly expanding knowledge base, pharmacists can have a significant impact on the prevention and treatment of cardiovascular disease–if they keep current with developments in drug therapy. Address comments to Patricia A. Howard, PharmD, Professor and Vice Chair, Pharmacy Practice, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160-7231. E-mail: [email protected] .

Download Full-text